Eculizumab therapy on a patient with co‐existent lupus nephritis and C3 mutation‐related atypical haemolytic uremic syndrome: a case report

BACKGROUND: Thrombotic microangiopathy (TMA), a rare but serious complication of systemic lupus erythematosus (SLE), is associated with poor outcomes to conventional immunosuppressive therapy. Recently, eculizumab, a humanised monoclonal antibody that blocks the complement factor 5, has been known t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mi Jung, Lee, Haekyung, Kim, Yon Hee, Jin, So Young, Kim, Hee-Jin, Oh, Doyeun, Jeon, Jin Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944615/
https://www.ncbi.nlm.nih.gov/pubmed/33691638
http://dx.doi.org/10.1186/s12882-021-02293-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7944615/
https://www.ncbi.nlm.nih.gov/pubmed/33691638
http://dx.doi.org/10.1186/s12882-021-02293-2

Ejemplares similares